What is Black Diamond Therapeutics, Inc. Common Stock's Market Cap?

Black Diamond Therapeutics, Inc. Common Stock's Market Cap is $120.7M, based on as-reported figures from SEC (XBRL) filings.

What is Black Diamond Therapeutics, Inc. Common Stock's Enterprise Value?

Black Diamond Therapeutics, Inc. Common Stock's Enterprise Value is $101.5M, based on as-reported figures from SEC (XBRL) filings.

What is Black Diamond Therapeutics, Inc. Common Stock's EV / EBITDA?

Black Diamond Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Black Diamond Therapeutics, Inc. Common Stock's Revenue (TTM)?

Black Diamond Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Black Diamond Therapeutics, Inc. Common Stock's Net Income (TTM)?

Black Diamond Therapeutics, Inc. Common Stock's Net Income (TTM) is -$42.6M, based on as-reported figures from SEC (XBRL) filings.

What is Black Diamond Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Black Diamond Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.74, based on as-reported figures from SEC (XBRL) filings.

What is Black Diamond Therapeutics, Inc. Common Stock's Net Debt?

Black Diamond Therapeutics, Inc. Common Stock's Net Debt is -$19.2M, based on as-reported figures from SEC (XBRL) filings.

Black Diamond Therapeutics, Inc. Common Stock (BDTX) Financial Statements

Black Diamond Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00MS4Y0X8

XNAS · usd

2.10▲ 0.00 (0.00%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close2.10

Day's Range2.07 – 2.15

52-Week Range1.60 – 4.94

Volume402.1K

Avg Volume572.6K

Share Statistics

Shares Outstanding

Employees21

ExchangeXNAS

Listed2020-01-30

Share count as of July 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Black Diamond Therapeutics, Inc. Common Stock (BDTX)

What is Black Diamond Therapeutics, Inc. Common Stock's Market Cap?: Black Diamond Therapeutics, Inc. Common Stock's Market Cap is $120.7M, based on as-reported figures from SEC (XBRL) filings.
What is Black Diamond Therapeutics, Inc. Common Stock's Enterprise Value?: Black Diamond Therapeutics, Inc. Common Stock's Enterprise Value is $101.5M, based on as-reported figures from SEC (XBRL) filings.
What is Black Diamond Therapeutics, Inc. Common Stock's EV / EBITDA?: Black Diamond Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Black Diamond Therapeutics, Inc. Common Stock's Revenue (TTM)?: Black Diamond Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Black Diamond Therapeutics, Inc. Common Stock's Net Income (TTM)?: Black Diamond Therapeutics, Inc. Common Stock's Net Income (TTM) is -$42.6M, based on as-reported figures from SEC (XBRL) filings.
What is Black Diamond Therapeutics, Inc. Common Stock's EBITDA?: Black Diamond Therapeutics, Inc. Common Stock's EBITDA is -$51.7M, based on as-reported figures from SEC (XBRL) filings.
What is Black Diamond Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Black Diamond Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.74, based on as-reported figures from SEC (XBRL) filings.
What is Black Diamond Therapeutics, Inc. Common Stock's Net Debt?: Black Diamond Therapeutics, Inc. Common Stock's Net Debt is -$19.2M, based on as-reported figures from SEC (XBRL) filings.